Zacks: Analysts Anticipate United Therapeutics Corporation (UTHR)...


Equities research analysts predict that United Therapeutics Corporation will post sales of $406.47 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have issued estimates for United Therapeutics Corporation's earnings.



from Biotech News